Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
ALPACA briefly breaks through $0.51, setting a new recent high, with $10.89 million in liquidations in the past 4 hours, ranked Top 1 across the network

ALPACA briefly breaks through $0.51, setting a new recent high, with $10.89 million in liquidations in the past 4 hours, ranked Top 1 across the network

BlockBeatsBlockBeats2025/04/30 05:28
Show original

Blockbeats news, on April 30, according to market data, ALPACA briefly broke through $0.51, marking a new high in the upward trend since "delisting from CEX" (a cumulative increase of over 1600%), currently quoted at $0.4486, with a 24-hour increase of 81.6%.

 

According to Coinglass data, ALPACA's 24-hour contract trading volume across the network reached $3.352 billion, with the current contract open interest at $115 million. In the past 4 hours, the network saw liquidations totaling $10.89 million, becoming the contract pair with the highest liquidation volume in the past 4 hours. Specifically, long positions were liquidated for $225,000, and short positions for $10.66 million. Notably, this liquidation amount also exceeded the combined total of BTC, ETH, and SOL data for the same period ($4.68 million + $3.66 million + $1.05 million = $9.39 million).

10
3

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.